One trial will compare those receiving puberty-supressing drugs and non-medical care with those receiving non-medical care ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and ...

New research unveiled at the American Heart Association’s Scientific Sessions highlights emerging strategies to prevent heart ...

Aston University's Dr Jonathan Cox and New Zealand Mānuka honey company Comvita have announced a significant milestone in ...

A new proteomic analysis is shedding a fresh light on the cytokine networks fueling idiopathic pulmonary fibrosis (IPF), ...

The complaint against Gambhir followed a direction from a division bench of the high court asking the agency to investigate ...

Children with gender dysphoria ‘could remain on puberty blockers after trial’ - Plans for a puberty blockers trial were ...

QMedic reports a $2,000 Medicare drug cost cap starting in 2026, ensuring predictable spending and potentially avoiding ...

Throughout time, viruses and bacteria have engaged in an endless competition for survival. Bacteria are ever-evolving to ...

A 16-count indictment charges Antonio “Fat Boy” Baez, 26; Cory “City” Lewis, 36; Javon Hutley, 33; and Roger Moody, 42, with ...

The call is coming from inside the house: Top FDA drug regulator Richard Pazdur, who was appointed to the role earlier this month, has raised alarms about the agency’s various plans to expedite drug ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...